The Buy rating and price target of $6 announced by JonesTrading analyst Sean Kim for Clearside Biomedical (NASDAQ:CLSD) is likely to have a positive short-term impact on the stock price. Investors may see this as a sign of confidence in the company's potential and future performance, leading to increased demand for the stock and a potential increase in its price.